ORGANIC
LETTERS
2012
Vol. 14, No. 6
1644–1647
Total Synthesis of (À)-Kaitocephalin
Based on a Rh-Catalyzed CÀH Amination
Keisuke Takahashi, Daisuke Yamaguchi, Jun Ishihara, and Susumi Hatakeyama*
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki,
852-8521, Japan
Received February 21, 2012
ABSTRACT
A total synthesis of (À)-kaitocephalin, an ionotropic glutamate receptor antagonist, is accomplished in highly stereocontrolled manner via
Overman rearrangement, rhodium-catalyzed benzylic CÀH amination, pyrrolidine formation involving nucleophilic opening of a cyclic sulfamate,
and rhodium-catalyzed allylic CÀH amination as key steps.
In 1997, Shin-ya and co-workers isolated kaitocephalin
(1) from Eupenicillium shearii PF1191.1 This structurally
novel amino acid has attracted much attention due to its
potent antagonistic activity against ionotropic glutamate
receptors.1,2 Excessive stimulation of these receptors by
glutamic acid or other agonists causes a variety of neuro-
degenerative disorders including epilepsy, stroke, Parkin-
son’s disease, and Alzheimer’s disease.3 Since antagonists
of glutamate receptors are effective for the protection of
neuronal injury or death, kaitocephalin (1) has potential as
a promising lead compound for developing therapeutic
agents against various neuronal diseases. However, de-
tailed neurobiological studies and SAR studies have been
hampered at present by the fact that the fungus has not
produced a sufficient amount of kaitocephalin (1). Such
extremely low availability from natural sources as well
as the intriguing biological properties and structural
challenges has made kaitocephalin (1) and its analogues
attractive targets for synthesis. Thus, there have been a
number of the synthetic studies4,5 including total syntheses
achieved by four groups.6À9 In connection with our pro-
ject directed toward the synthesis of natural products
which selectively interact with ionotropic glutamate recep-
tors,4c,10 we became interested in the synthesis of
(4) Synthetic approaches to 1: (a) Loh, T.-P.; Chok, Y.-K.; Yin, Z.
Tetrahedron Lett. 2001, 42, 7893–7897. (b) Kudryavtsev, K. V.;
Nukolova, N. V.; Kokoreva, O. V.; Smolin, E. S. Russ. J. Org. Chem.
2006, 42, 412–422. (c) Takahashi, K.; Haraguchi, N.; Ishihara, J.;
Hatakeyama, S. Synlett 2008, 671–674.
(5) Total synthesis of 2-epimer of 1: Ma, D.; Yang., J. J. Am. Chem.
Soc. 2001, 123, 9706–9707.
(6) (a) Okue, M.; Kobayashi, H.; Shin-ya, K.; Furihata, K.;
Hayakawa, Y.; Seto, H.; Watanabe, H.; Kitahara, T. Tetrahedron Lett.
2002, 43, 857–860. (b) Watanabe, H.; Okue, M.; Kobayashi, H.;
Kitahara, T. Tetrahedron Lett. 2002, 43, 861–864. (c) Doi, F.; Watanabe,
H. 49th Symposium on the Chemistry of Natural Products, 2007
(Sapporo), pp 533À538.
(7) (a) Kawasaki, M.; Shinada, T.; Hamada, M.; Ohfune, Y. Org.
Lett. 2005, 7, 4165–4167. (b) Hamada, M.; Shinada, T.; Ohfune, Y. Org.
Lett. 2009, 11, 4664–4667.
(1) (a) Shin-Ya, K.; Kim, J.-S.; Furihata, K.; Hayakawa, Y.; Seto, H.
Tetrahedron Lett. 1997, 38, 7079–7082. (b) Kobayashi, H.; Shin-Ya, K.;
Furihata, K.; Hayakawa, Y.; Seto, H. Tetrahedron Lett. 2001, 42, 4021–
4023.
(8) Vasawani, R. G.; Chamberlin, R. J. Org. Chem. 2008, 73, 1661–
1681.
(2) Limon, A.; Reyes-Ruiz, J. M.; Vaswani, R. G.; Chamberlin,
A. R.; Miledi, R. ACS Chem. Neurosci. 2010, 1, 175–181. Kaitocephalin
inhibits NMDA and AMPA receptors but has only slight effects on KA
receptors.
(3) Bigge, C. E. Curr. Opin. Chem. Biol. 1999, 3, 441–447. (b) Mayer,
M. L. Current Opin. Neurobiol. 2005, 15, 282–288. (c) Dingledine, R.;
Borges, K.; Bowie, D.; Traynelis, S. F. Pharmcol. Rev. 1999, 51, 7–61. (d)
Madden, D. R. Nat. Rev. Neurosci. 2002, 3, 91–101.
(9) Yu, S.; Zhu, S.; Pan, X.; Yang, J.; Ma, D. Tetrahedron 2011, 67,
1673–1680.
(10) (a) Masaki, H.; Maeyama, J.; Kamada, K.; Esumi, T.; Iwabuchi,
Y.; Hatakeyama, S. J. Am. Chem. Soc. 2000, 122, 5216–5217. (b)
Takahashi, K.; Matsumura, T.; Ishihara, J.; Hatakeyama, S. Chem.
Commun. 2007, 4158–4160. (c) Takahashi, K.; Matsumura, T.; Corbin,
G. R. M.; Ishihara, J.; Hatakeyama, S. J. Org. Chem. 2006, 71, 4227–
4231.
r
10.1021/ol300431n
Published on Web 03/05/2012
2012 American Chemical Society